19 completed, 8 terminated, 6 recruiting, 3 unknown. 43 Phase 1, 11 Phase 2.
Follow Propranolol: new trials by email Literature Review of Propranolol trials Research Report on Propranolol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Neoadjuvant Propranolol Plus SOX and Toripalimab for Locally Advanced Gastric/GEJ Adenocarcinoma propranolol, Toripalimab, Oxaliplatin - Gastric or Gastroesophageal Junction Adenocarcinoma, Propranolol | Phase 1 / Phase 2 | Not yet recruiting | Ting Liu | 49 | 2026-08-01 | 2026-07-27 |
| Propranolol Hydrochloride Combined With Toripalimab and Platinum-based Chemotherapy in Resectable Non-Small Cell Lung Cancer Propranolol Hydrochloride, Toripalimab, Chemotherapy - Resectable Non-Small-Cell Lung Cancer | Phase 1 | Recruiting | Second Xiangya Hospital of Central South University | 9 | 2026-06-01 | 2026-10-21 |
| Propranolol Hydrochloride Combined With Adebrelimab and Platinum-Based Chemotherapy in Small Cell Lung Cancer Propranolol Hydrochloride, Adebrelimab, Chemotherapy - Small Cell Lung Cancer (SCLC) | Phase 1 | Recruiting | Second Xiangya Hospital of Central South University | 18 | 2026-05-29 | 2026-10-21 |
| Propranolol Plus Standard Radiation Therapy Before Surgery for the Treatment of Patients With Soft Tissue Sarcoma Biopsy, Biospecimen Collection, Computed Tomography - Soft Tissue Sarcoma | Phase 1 | Withdrawn | Roswell Park Cancer Institute | 2026-05-15 | 2025-08-26 | |
| Propranolol With Tislelizumab Plus GC in Neoadjuvant Bladder UC propranolol, Tislelizumab, gemcitabine - Bladder Urothelial Carcinoma, Lymph Node Metastasis | Phase 1 | Enrolling by invitation | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 12 | 2026-01-01 | 2026-04-22 |
| Propranolol Treatment for Postoperative Chylothorax Propranolol Hydrochloride, Placebo - Postoperative Chylothorax, Congenital Heart Disease | Phase 1 / Phase 2 | Suspended | June Wu | 50 | 2025-09-09 | 2026-05-15 |
| Evaluating the Impact of Adjuvant Use of Beta Blockers on Clinical Outcomes in Patients With Traumatic Brain Injury control, propranolol, Carvedilol - TBI Traumatic Brain Injury | Phase 1 / Phase 2 | Recruiting | Mansoura University | 100 | 2025-01-20 | 2025-04-02 |
| Propranolol Hydrochloride in Combination With Sintilimab and Platinum-based Chemotherapy for Treatment of Advanced Non-small Cell Lung Cancer Propranolol hydrochloride, Sintilimab, Chemotherapy - Non Small Cell Lung Cancer, Propranolol | Phase 1 | Recruiting | Second Xiangya Hospital of Central South University | 6 | 2024-11-13 | 2024-11-19 |
| Naltrexone and Propranolol Combined With Immunotherapy Propranolol, Naltrexone - Advanced Melanoma | Phase 1 | Recruiting | Sarah Weiss | 12 | 2023-09-11 | 2025-09-18 |
| Beta-blocker Administration for Cardiomyocyte Division N-thymidine, Urine Collection, Echocardiogram - Tetralogy of Fallot, Double Outlet Right Ventricle | Phase 1 | Recruiting | Weill Medical College of Cornell University | 40 | 2022-12-16 | 2026-10-26 |
| A Trial to Assess the Effects of Prazosin or Propranolol on Blood Pressure in the Presence of Brexpiprazole/Sertraline Propranolol, Prazosin - Post-traumatic Stress Disorder (PTSD) | Phase 1 | Terminated | Otsuka Pharmaceutical Development & Commercialization, Inc. | 34 | 2022-09-07 | 2024-01-23 |
| Propranolol for Protracted Labor Propranolol - Labour;Obstructed, Labor Dystocia | Phase 1 | Completed | Christiana Care Health Services | 80 | 2021-07-27 | 2022-07-28 |
| A Study of Ponesimod in Healthy Adult Participants Receiving Propranolol at Steady State Ponesimod dose range (2 - 20 mg), Placebo Propranolol, Propranolol 80 mg - Healthy | Phase 1 | Completed | Janssen Pharmaceutica N.V., Belgium | 52 | 2019-03-20 | 2025-04-27 |
| Efficacy Evaluation of Propranolol Treatment of Hepatic Hemangioma Propranolol Hydrochloride - Hemangioma Liver | Phase 1 / Phase 2 | Terminated | Second Affiliated Hospital, Zhejiang University, School of Medicine | 8 | 2018-07-01 | 2025-05-22 |
| Oral Propanolol for Surgically Inaccessible Cavernous Malformations Propranolol Oral Tablet, Placebo Oral Tablet - Cavernous Malformations,Cerebral and/or Spinal | Phase 1 | Unknown | University of Virginia | 346 | 2018-02-07 | 2018-05-14 |
| Propranolol Hydrochloride and Pembrolizumab in Treating Patients With Stage IIIC-IV Melanoma That Cannot Be Removed by Surgery Laboratory Biomarker Analysis, Pembrolizumab, Propranolol Hydrochloride - Stage IIIC Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7 | Phase 1 / Phase 2 | Suspended | Roswell Park Cancer Institute | 47 | 2018-01-31 | 2026-07-15 |
| Brief Stresses Experimental Study Propranolol, Placebo oral capsule, Acute stress task - DNA Damage, Psychological Stress | Phase 1 | Terminated | Dana Bovbjerg | 239 | 2017-10-05 | 2023-07-18 |
| A Study of Lasmiditan and Propranolol in Healthy Participants Lasmiditan, Propranolol - Healthy | Phase 1 | Completed | Eli Lilly and Company | 44 | 2017-08-31 | 2019-12-16 |
| Propranolol for Treating Fibromyalgia Pain Propranolol 1, Propranolol 2, Placebo - Fibromyalgia Pain | Phase 1 | Terminated | University of Utah | 15 | 2017-01-01 | 2018-08-23 |
| Dose-Finding of Propranolol in Combination With Metronomic Fixed Oral Cyclophosphamide Based on Bivariate Efficacy-tolerability Outcome in Patients With Locally Advanced or Metastatic Angiosarcoma: A Collaborative and Innovative Phase I-II Sequential Trial by the French Sarcoma Group (GSF/GETO) PROPRANOLOL - Angiosarcoma | Phase 1 / Phase 2 | Unknown | Assistance Publique Hopitaux De Marseille | 24 | 2016-05-01 | 2016-04-11 |
Showing 20 of 43. Sign in to see all of them.
Brain Injuries, Traumatic (2) · Carcinoma, Non-Small-Cell Lung (2) · Depressive Disorder, Major (2) · Melanoma (2) · Pulmonary Disease, Chronic Obstructive (2) · Stress Disorders, Post-Traumatic (2) · Stress, Psychological (2) · Anemia, Sickle Cell (1) · Arteriosclerosis (1) · Autonomic Nervous System Diseases (1) · Brain Injuries (1) · Chylothorax (1) · Cocaine-Related Disorders (1) · Diabetes Mellitus (1) · Diabetes Mellitus, Type 2 (1)
Second Xiangya Hospital of Central South University (3) · Actavis Inc. (2) · Boehringer Ingelheim (2) · Eli Lilly and Company (2) · Roswell Park Cancer Institute (2) · Assistance Publique Hopitaux De Marseille (1) · Astellas Pharma Inc (1) · Christiana Care Health Services (1) · Dana Bovbjerg (1) · GlaxoSmithKline (1) · Janssen Pharmaceutica N.V., Belgium (1) · Johns Hopkins University (1) · June Wu (1) · Mansoura University (1) · Merck Sharp & Dohme LLC (1)
United States (24) · China (5) · France (2) · United Kingdom (2) · Belgium (1) · Egypt (1) · Germany (1) · Israel (1) · Switzerland (1)
James D. Carlson,, Pharm.D, (2) · Akiko Okifuji, PhD (1) · Anurag K Singh (1) · Bernhard Kuhn, MD (1) · Dana Bovbjerg, PhD (1) · Frank Jenkins, PhD (1) · Helen B Gomez, MD (1) · Joachim E Fischer, MD, MSc (1) · June Wu, MD (1) · Kenzie Preston, Ph.D. (1) · Leslie Z Benet, PhD (1) · Lynda Frassetto, MD (1)
PMID 15583741, PMID 15890495, PMID 15911704, PMID 15978266, PMID 18550886, PMID 19687359, PMID 19840322, PMID 20117846, PMID 20644039, PMID 20732454, PMID 20797926, PMID 20936416, PMID 24002370, PMID 24227635, PMID 24495468, PMID 24606242, PMID 24721800, PMID 32673517, PMID 34265312
2015 (1), 2018 (1), R01CA211371 (1), R01HL155597 (1), U54DA037842 (1), UL1TR000445 (1)